Canada · Health Canada Drug Product Database
DIURENYL TAB
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 2967
- DIN
- 00431443
- Form
- Tablet
- Company as listed by source
- LABORATOIRE LALCO INC.
- Source status
- Cancelled Post Market (2004-07-26)
- Source last updated
- 2025-03-22
Source-listed ingredients
- POTASSIUM NITRATE — 97.2 MG
- BUCHU — 64.8 MG
- COLLINSONIA CANADENSIS — 32.4 MG
- UVA URSI — 48.6 MG
These values do not establish equivalence or a dose recommendation.
Packages
- 100
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →